Skip to main content
Membership NewsMembership News Archive

Join industry roundtable and tour of Institute of Cancer Research (ICR), London

By May 26, 2026No Comments

Oncology innovators are invited to join industry roundtable and tour of Institute of Cancer Research (ICR), London.

Developing new treatments, tools and systems to fight cancer increasingly depends on access to advanced scientific infrastructure, clinical expertise, patient datasets, specialist laboratory services, and translational research capabilities.

​The London Cancer Hub, in partnership with the Institute of Cancer Research (ICR), The Royal Marsden NHS Foundation Trust, Socius and Populate, are opening access to a growing suite of scientific assets and innovation support services designed to help pioneering companies accelerate their R&D journeys.

​The industry roundtable and networking session means you will:

  • ​Tour the ICR’s core research facilities
  • ​Meet research scientists and technical specialists
  • ​Explore emerging infrastructure and service opportunities at the London Cancer Hub
  • ​Share insights on how these capabilities can best support innovative companies

​They are particularly keen to hear your views on:

  • ​The equipment and infrastructure you need
  • ​How you would want to access and use these capabilities
  • ​Scientific and technical support requirements
  • ​Existing expertise gaps or partnership opportunities
  • ​Preferred commercial models, productisation and service packaging

​The session will include refreshments, discussion with peers from across the innovation ecosystem, and an optional guided tour of the ICR’s core facilities.

They will host two sessions on Monday 15 June. Please click on the link to join them for the one that is most convenient for you:

​Lunch Roundtable 12:00 – 14:00: https://luma.com/veccj3cp

OR

​Afternoon Tea Roundtable 16:00 – 18:00: https://luma.com/tgxjqljk

​They are very keen to support companies in accessing and shaping the ecosystem being developed at the London Cancer Hub, and would greatly value your perspective.

Ben Kemp